BFST vs EQBK

BFST presents a compelling value opportunity, trading significantly below its Graham Number ($41.89) and Intrinsic Value ($82.31). While the Piotroski F-Score of 4/9 indicates stable but not exceptional financial health, the company demonstrates exceptional earnings quality with a consistent track record of beating estimates over 25 quarters. Strong YoY earnings growth of 37.6% and a Price-to-Book ratio of 1.01 suggest the market is severely underpricing the bank's assets and growth trajectory. The primary headwinds are technical bearishness and insider selling, which contrast sharply with the strong fundamental data.

EQBK presents a stark contrast between fundamental health and market expectations. The deterministic health baseline is weak, highlighted by a Piotroski F-Score of 2/9, indicating significant deterioration in financial strength. While the stock trades at a substantial premium to its Graham Number ($32.33) and Intrinsic Value ($8.26), it is supported by a consistent track record of earnings beats and strong revenue growth (33% YoY). The massive discrepancy between the current P/E (38.42) and Forward P/E (8.61) suggests the market is pricing in a major earnings recovery that has yet to fully materialize in the ROE (3.44%).